Bayer Consumer Health launches microbiome research call to find new academic partners
Campaign launch date: Monday, July 18, 2022. Bayer Consumer Health has launched a call through…
July 19, 2022 - 3 minutes
Microbiome: An Emerging Field with Growing Investments
The potential of the microbiome to be used for the development of promising therapeutics and diagnostic approaches has spurred a hype around this emerging field. Over the last decade, researchers have found correlations between the human microbiome and a number of diseases, including inflammatory bowel disease, diabetes, autoimmune diseases, cancer, depression, and many more. As the number of clinical trials grows, investor interest is increasing.
Read on to find out more about the flourishing microbiome field and how it shows promise for the treatment of a large variety of diseases.
Show More
Editor's Picks for Microbiome
- UK Startup Surfs Investment Wave in Microbiome with €18M Series A
- Microbiome Medicines Could Power Up CAR-T Cell Therapies
- Investing in the Microbiome in the Age of Covid-19 and Beyond
- The Missing Piece in the Microbiome Field
- No Guts, No Glory: How Microbiome Research is Changing Medicine
Beyond the Gut: An Atlas of the Human Microbiome
This report discusses the role of the gut and blood microbiomes in different diseases and how they can be used for biomarker discovery and for the development of therapeutics.
Go to ReportLatest Microbiome Articles
Paradigm of treatment of mental health to be transformed by gut-brain development program
Building on a decade of research, a development program for next-generation probiotics and therapeutics to…
July 13, 2022 - 3 minutes
The five most advanced microbiome players aiming for the gut
After decades of research, gut microbiome therapies are on the cusp of reaching the market.…
July 6, 2022 - 6 minutes
Novartis Pharmaceuticals UK launches health-tech investor partnership for cardiovascular care
Novartis Pharmaceuticals UK has launched the Novartis Biome UK Heart Health Catalyst 2022, in a…
July 5, 2022 - 4 minutes
Sponsored
by Computomics
Metagenomics: unlocking the secrets of microbial communities
The combination of advanced sequencing technologies and user-friendly data analysis solutions is bringing metagenomics into…
July 5, 2022 - 6 minutes
Fermentation facility opens its doors in Wisconsin
A new fermentation facility producing food ingredients and cultures, bacterial cultures, and probiotics has been…
June 27, 2022 - 2 minutes
Releasing the microbiome’s potential to restore European soils
For decades, soil has been treated as an everlasting food machine rather than as a…
June 6, 2022 - 9 minutes
Ilya Pharma Paves Way for Bacterial Gene Therapy with €8.5M Funding
Cell and gene therapies are taking off in a big way in Europe. As the…
March 23, 2022 - 4 minutes
Microbiome Space in Spotlight as Microbiotica Sets Funding Record
Competition is heating up in the microbiome niche as UK-based Microbiotica raised €60M (£50M) in…
March 11, 2022 - 3 minutes
UK Startup Surfs Investment Wave in Microbiome with €18M Series A
As increasing attention turns to microbiome-based therapeutics, the Scottish biotech Enterobiotix has closed a Series…
September 15, 2021 - 4 minutes
Microbiome Medicines Could Power Up CAR-T Cell Therapies
The microbiome could pave new cancer immunotherapy inroads for European biotechs, bolstered by preclinical findings…
July 28, 2021 - 5 minutes
Scotland’s Top 10 Biotech Companies to Watch Out For
Scotland has a thriving life sciences ecosystem with strengths in oncology, genetic engineering, and industrial…
June 30, 2021 - 11 minutes
